Advanced Science-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209274, encodeId=1d4122092e4b4, content=偏重的研究方向：医学;基础医学 经验分享：大佬们，想请教一下，论文送审后拒概率高吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Mon Jun 10 22:52:28 CST 2024, time=2024-06-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向：临床医学 经验分享：这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2199501, encodeId=993e2199501d6, content=偏重的研究方向：医学 经验分享：投了三个月，under review了快三个月，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff0e9138354, createdName=ms1000000197918585, createdTime=Sat Apr 20 22:11:40 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215173, encodeId=aa9122151e352, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：这个期刊太慢了，一审3个多月，又搞了二轮三轮，然后本来都预接收了，结果因为刚开始投稿的时候系统里多写了一个作者的名字，最后三审修回的时候才发现就给系统里删了，但是文章里作者没变，编辑让我解释，我回信解释后编辑又说送reviewer外审了。。。。有没有人和我一样的情况的？为啥三个审稿人都同意发表了只是系统里更改了填错的作者就要重新送审啊？难道又要拖好几个月吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FNCj07F0t899iaIQqGfFvjw&s=100, createdBy=44e32581133, createdName=圆圈, createdTime=Tue Jul 16 07:22:48 CST 2024, time=2024-07-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204586, encodeId=948b2204586bd, content=under review两个半月了，有必要催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec646521427, createdName=ms6000001850112323, createdTime=Tue May 14 09:51:07 CST 2024, time=2024-05-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208315, encodeId=76a42208315dd, content=5.2号提交。5.11送审。6.1号审回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Tue Jun 04 20:40:58 CST 2024, time=2024-06-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2211742, encodeId=72562211e42a5, content=有没有大佬知道，返修可以调整部分作者排名顺序吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Wed Jun 26 15:30:42 CST 2024, time=2024-06-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2209010, encodeId=efa52209010b7, content=偏重的研究方向：医学;肿瘤 经验分享：刚submit，mark一下，接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Sat Jun 08 23:56:01 CST 2024, time=2024-06-08, status=1, ipAttribution=重庆)]

2024-05-18 1208f9b9m90暂无昵称来自北京

想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？

20 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209274, encodeId=1d4122092e4b4, content=偏重的研究方向：医学;基础医学 经验分享：大佬们，想请教一下，论文送审后拒概率高吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Mon Jun 10 22:52:28 CST 2024, time=2024-06-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向：临床医学 经验分享：这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2199501, encodeId=993e2199501d6, content=偏重的研究方向：医学 经验分享：投了三个月，under review了快三个月，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff0e9138354, createdName=ms1000000197918585, createdTime=Sat Apr 20 22:11:40 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215173, encodeId=aa9122151e352, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：这个期刊太慢了，一审3个多月，又搞了二轮三轮，然后本来都预接收了，结果因为刚开始投稿的时候系统里多写了一个作者的名字，最后三审修回的时候才发现就给系统里删了，但是文章里作者没变，编辑让我解释，我回信解释后编辑又说送reviewer外审了。。。。有没有人和我一样的情况的？为啥三个审稿人都同意发表了只是系统里更改了填错的作者就要重新送审啊？难道又要拖好几个月吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FNCj07F0t899iaIQqGfFvjw&s=100, createdBy=44e32581133, createdName=圆圈, createdTime=Tue Jul 16 07:22:48 CST 2024, time=2024-07-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204586, encodeId=948b2204586bd, content=under review两个半月了，有必要催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec646521427, createdName=ms6000001850112323, createdTime=Tue May 14 09:51:07 CST 2024, time=2024-05-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208315, encodeId=76a42208315dd, content=5.2号提交。5.11送审。6.1号审回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Tue Jun 04 20:40:58 CST 2024, time=2024-06-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2211742, encodeId=72562211e42a5, content=有没有大佬知道，返修可以调整部分作者排名顺序吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Wed Jun 26 15:30:42 CST 2024, time=2024-06-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2209010, encodeId=efa52209010b7, content=偏重的研究方向：医学;肿瘤 经验分享：刚submit，mark一下，接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Sat Jun 08 23:56:01 CST 2024, time=2024-06-08, status=1, ipAttribution=重庆)]

2024-06-10 ms4000000919063399 来自安徽省

偏重的研究方向：医学;基础医学
经验分享：大佬们，想请教一下，论文送审后拒概率高吗🥹

25 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209274, encodeId=1d4122092e4b4, content=偏重的研究方向：医学;基础医学 经验分享：大佬们，想请教一下，论文送审后拒概率高吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Mon Jun 10 22:52:28 CST 2024, time=2024-06-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向：临床医学 经验分享：这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2199501, encodeId=993e2199501d6, content=偏重的研究方向：医学 经验分享：投了三个月，under review了快三个月，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff0e9138354, createdName=ms1000000197918585, createdTime=Sat Apr 20 22:11:40 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215173, encodeId=aa9122151e352, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：这个期刊太慢了，一审3个多月，又搞了二轮三轮，然后本来都预接收了，结果因为刚开始投稿的时候系统里多写了一个作者的名字，最后三审修回的时候才发现就给系统里删了，但是文章里作者没变，编辑让我解释，我回信解释后编辑又说送reviewer外审了。。。。有没有人和我一样的情况的？为啥三个审稿人都同意发表了只是系统里更改了填错的作者就要重新送审啊？难道又要拖好几个月吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FNCj07F0t899iaIQqGfFvjw&s=100, createdBy=44e32581133, createdName=圆圈, createdTime=Tue Jul 16 07:22:48 CST 2024, time=2024-07-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204586, encodeId=948b2204586bd, content=under review两个半月了，有必要催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec646521427, createdName=ms6000001850112323, createdTime=Tue May 14 09:51:07 CST 2024, time=2024-05-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208315, encodeId=76a42208315dd, content=5.2号提交。5.11送审。6.1号审回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Tue Jun 04 20:40:58 CST 2024, time=2024-06-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2211742, encodeId=72562211e42a5, content=有没有大佬知道，返修可以调整部分作者排名顺序吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Wed Jun 26 15:30:42 CST 2024, time=2024-06-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2209010, encodeId=efa52209010b7, content=偏重的研究方向：医学;肿瘤 经验分享：刚submit，mark一下，接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Sat Jun 08 23:56:01 CST 2024, time=2024-06-08, status=1, ipAttribution=重庆)]

2024-03-06 ms1000001659923753 来自密苏里

偏重的研究方向：临床医学
经验分享：这个和cell reports比怎么样

91 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209274, encodeId=1d4122092e4b4, content=偏重的研究方向：医学;基础医学 经验分享：大佬们，想请教一下，论文送审后拒概率高吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Mon Jun 10 22:52:28 CST 2024, time=2024-06-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向：临床医学 经验分享：这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2199501, encodeId=993e2199501d6, content=偏重的研究方向：医学 经验分享：投了三个月，under review了快三个月，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff0e9138354, createdName=ms1000000197918585, createdTime=Sat Apr 20 22:11:40 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215173, encodeId=aa9122151e352, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：这个期刊太慢了，一审3个多月，又搞了二轮三轮，然后本来都预接收了，结果因为刚开始投稿的时候系统里多写了一个作者的名字，最后三审修回的时候才发现就给系统里删了，但是文章里作者没变，编辑让我解释，我回信解释后编辑又说送reviewer外审了。。。。有没有人和我一样的情况的？为啥三个审稿人都同意发表了只是系统里更改了填错的作者就要重新送审啊？难道又要拖好几个月吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FNCj07F0t899iaIQqGfFvjw&s=100, createdBy=44e32581133, createdName=圆圈, createdTime=Tue Jul 16 07:22:48 CST 2024, time=2024-07-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204586, encodeId=948b2204586bd, content=under review两个半月了，有必要催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec646521427, createdName=ms6000001850112323, createdTime=Tue May 14 09:51:07 CST 2024, time=2024-05-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208315, encodeId=76a42208315dd, content=5.2号提交。5.11送审。6.1号审回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Tue Jun 04 20:40:58 CST 2024, time=2024-06-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2211742, encodeId=72562211e42a5, content=有没有大佬知道，返修可以调整部分作者排名顺序吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Wed Jun 26 15:30:42 CST 2024, time=2024-06-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2209010, encodeId=efa52209010b7, content=偏重的研究方向：医学;肿瘤 经验分享：刚submit，mark一下，接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Sat Jun 08 23:56:01 CST 2024, time=2024-06-08, status=1, ipAttribution=重庆)]

2024-04-20 ms1000000197918585 来自江苏省

偏重的研究方向：医学
经验分享：投了三个月，under review了快三个月，不知道还要等多久

60 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209274, encodeId=1d4122092e4b4, content=偏重的研究方向：医学;基础医学 经验分享：大佬们，想请教一下，论文送审后拒概率高吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Mon Jun 10 22:52:28 CST 2024, time=2024-06-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向：临床医学 经验分享：这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2199501, encodeId=993e2199501d6, content=偏重的研究方向：医学 经验分享：投了三个月，under review了快三个月，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff0e9138354, createdName=ms1000000197918585, createdTime=Sat Apr 20 22:11:40 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215173, encodeId=aa9122151e352, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：这个期刊太慢了，一审3个多月，又搞了二轮三轮，然后本来都预接收了，结果因为刚开始投稿的时候系统里多写了一个作者的名字，最后三审修回的时候才发现就给系统里删了，但是文章里作者没变，编辑让我解释，我回信解释后编辑又说送reviewer外审了。。。。有没有人和我一样的情况的？为啥三个审稿人都同意发表了只是系统里更改了填错的作者就要重新送审啊？难道又要拖好几个月吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FNCj07F0t899iaIQqGfFvjw&s=100, createdBy=44e32581133, createdName=圆圈, createdTime=Tue Jul 16 07:22:48 CST 2024, time=2024-07-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204586, encodeId=948b2204586bd, content=under review两个半月了，有必要催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec646521427, createdName=ms6000001850112323, createdTime=Tue May 14 09:51:07 CST 2024, time=2024-05-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208315, encodeId=76a42208315dd, content=5.2号提交。5.11送审。6.1号审回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Tue Jun 04 20:40:58 CST 2024, time=2024-06-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2211742, encodeId=72562211e42a5, content=有没有大佬知道，返修可以调整部分作者排名顺序吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Wed Jun 26 15:30:42 CST 2024, time=2024-06-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2209010, encodeId=efa52209010b7, content=偏重的研究方向：医学;肿瘤 经验分享：刚submit，mark一下，接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Sat Jun 08 23:56:01 CST 2024, time=2024-06-08, status=1, ipAttribution=重庆)]

2024-07-16 圆圈来自湖北省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤学
经验分享：这个期刊太慢了，一审3个多月，又搞了二轮三轮，然后本来都预接收了，结果因为刚开始投稿的时候系统里多写了一个作者的名字，最后三审修回的时候才发现就给系统里删了，但是文章里作者没变，编辑让我解释，我回信解释后编辑又说送reviewer外审了。。。。有没有人和我一样的情况的？为啥三个审稿人都同意发表了只是系统里更改了填错的作者就要重新送审啊？难道又要拖好几个月吗。。。

3 0

[GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209274, encodeId=1d4122092e4b4, content=偏重的研究方向：医学;基础医学 经验分享：大佬们，想请教一下，论文送审后拒概率高吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Mon Jun 10 22:52:28 CST 2024, time=2024-06-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向：临床医学 经验分享：这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2199501, encodeId=993e2199501d6, content=偏重的研究方向：医学 经验分享：投了三个月，under review了快三个月，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff0e9138354, createdName=ms1000000197918585, createdTime=Sat Apr 20 22:11:40 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215173, encodeId=aa9122151e352, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：这个期刊太慢了，一审3个多月，又搞了二轮三轮，然后本来都预接收了，结果因为刚开始投稿的时候系统里多写了一个作者的名字，最后三审修回的时候才发现就给系统里删了，但是文章里作者没变，编辑让我解释，我回信解释后编辑又说送reviewer外审了。。。。有没有人和我一样的情况的？为啥三个审稿人都同意发表了只是系统里更改了填错的作者就要重新送审啊？难道又要拖好几个月吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FNCj07F0t899iaIQqGfFvjw&s=100, createdBy=44e32581133, createdName=圆圈, createdTime=Tue Jul 16 07:22:48 CST 2024, time=2024-07-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204586, encodeId=948b2204586bd, content=under review两个半月了，有必要催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec646521427, createdName=ms6000001850112323, createdTime=Tue May 14 09:51:07 CST 2024, time=2024-05-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208315, encodeId=76a42208315dd, content=5.2号提交。5.11送审。6.1号审回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Tue Jun 04 20:40:58 CST 2024, time=2024-06-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2211742, encodeId=72562211e42a5, content=有没有大佬知道，返修可以调整部分作者排名顺序吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Wed Jun 26 15:30:42 CST 2024, time=2024-06-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2209010, encodeId=efa52209010b7, content=偏重的研究方向：医学;肿瘤 经验分享：刚submit，mark一下，接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Sat Jun 08 23:56:01 CST 2024, time=2024-06-08, status=1, ipAttribution=重庆)]

2024-03-22 122aa381m91(暂无昵称) 来自北京

审稿速度:12.0 | 投稿命中率:25.0
偏重的研究方向：基础医学
经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。

72 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209274, encodeId=1d4122092e4b4, content=偏重的研究方向：医学;基础医学 经验分享：大佬们，想请教一下，论文送审后拒概率高吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Mon Jun 10 22:52:28 CST 2024, time=2024-06-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向：临床医学 经验分享：这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2199501, encodeId=993e2199501d6, content=偏重的研究方向：医学 经验分享：投了三个月，under review了快三个月，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff0e9138354, createdName=ms1000000197918585, createdTime=Sat Apr 20 22:11:40 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215173, encodeId=aa9122151e352, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：这个期刊太慢了，一审3个多月，又搞了二轮三轮，然后本来都预接收了，结果因为刚开始投稿的时候系统里多写了一个作者的名字，最后三审修回的时候才发现就给系统里删了，但是文章里作者没变，编辑让我解释，我回信解释后编辑又说送reviewer外审了。。。。有没有人和我一样的情况的？为啥三个审稿人都同意发表了只是系统里更改了填错的作者就要重新送审啊？难道又要拖好几个月吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FNCj07F0t899iaIQqGfFvjw&s=100, createdBy=44e32581133, createdName=圆圈, createdTime=Tue Jul 16 07:22:48 CST 2024, time=2024-07-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204586, encodeId=948b2204586bd, content=under review两个半月了，有必要催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec646521427, createdName=ms6000001850112323, createdTime=Tue May 14 09:51:07 CST 2024, time=2024-05-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208315, encodeId=76a42208315dd, content=5.2号提交。5.11送审。6.1号审回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Tue Jun 04 20:40:58 CST 2024, time=2024-06-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2211742, encodeId=72562211e42a5, content=有没有大佬知道，返修可以调整部分作者排名顺序吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Wed Jun 26 15:30:42 CST 2024, time=2024-06-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2209010, encodeId=efa52209010b7, content=偏重的研究方向：医学;肿瘤 经验分享：刚submit，mark一下，接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Sat Jun 08 23:56:01 CST 2024, time=2024-06-08, status=1, ipAttribution=重庆)]

2024-05-14 ms6000001850112323 来自上海

under review两个半月了，有必要催一下吗

80 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209274, encodeId=1d4122092e4b4, content=偏重的研究方向：医学;基础医学 经验分享：大佬们，想请教一下，论文送审后拒概率高吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Mon Jun 10 22:52:28 CST 2024, time=2024-06-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向：临床医学 经验分享：这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2199501, encodeId=993e2199501d6, content=偏重的研究方向：医学 经验分享：投了三个月，under review了快三个月，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff0e9138354, createdName=ms1000000197918585, createdTime=Sat Apr 20 22:11:40 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215173, encodeId=aa9122151e352, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：这个期刊太慢了，一审3个多月，又搞了二轮三轮，然后本来都预接收了，结果因为刚开始投稿的时候系统里多写了一个作者的名字，最后三审修回的时候才发现就给系统里删了，但是文章里作者没变，编辑让我解释，我回信解释后编辑又说送reviewer外审了。。。。有没有人和我一样的情况的？为啥三个审稿人都同意发表了只是系统里更改了填错的作者就要重新送审啊？难道又要拖好几个月吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FNCj07F0t899iaIQqGfFvjw&s=100, createdBy=44e32581133, createdName=圆圈, createdTime=Tue Jul 16 07:22:48 CST 2024, time=2024-07-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204586, encodeId=948b2204586bd, content=under review两个半月了，有必要催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec646521427, createdName=ms6000001850112323, createdTime=Tue May 14 09:51:07 CST 2024, time=2024-05-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208315, encodeId=76a42208315dd, content=5.2号提交。5.11送审。6.1号审回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Tue Jun 04 20:40:58 CST 2024, time=2024-06-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2211742, encodeId=72562211e42a5, content=有没有大佬知道，返修可以调整部分作者排名顺序吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Wed Jun 26 15:30:42 CST 2024, time=2024-06-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2209010, encodeId=efa52209010b7, content=偏重的研究方向：医学;肿瘤 经验分享：刚submit，mark一下，接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Sat Jun 08 23:56:01 CST 2024, time=2024-06-08, status=1, ipAttribution=重庆)]

2024-06-04 ms3000001282718256 来自安徽省

5.2号提交。5.11送审。6.1号审回

54 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209274, encodeId=1d4122092e4b4, content=偏重的研究方向：医学;基础医学 经验分享：大佬们，想请教一下，论文送审后拒概率高吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Mon Jun 10 22:52:28 CST 2024, time=2024-06-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向：临床医学 经验分享：这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2199501, encodeId=993e2199501d6, content=偏重的研究方向：医学 经验分享：投了三个月，under review了快三个月，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff0e9138354, createdName=ms1000000197918585, createdTime=Sat Apr 20 22:11:40 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215173, encodeId=aa9122151e352, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：这个期刊太慢了，一审3个多月，又搞了二轮三轮，然后本来都预接收了，结果因为刚开始投稿的时候系统里多写了一个作者的名字，最后三审修回的时候才发现就给系统里删了，但是文章里作者没变，编辑让我解释，我回信解释后编辑又说送reviewer外审了。。。。有没有人和我一样的情况的？为啥三个审稿人都同意发表了只是系统里更改了填错的作者就要重新送审啊？难道又要拖好几个月吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FNCj07F0t899iaIQqGfFvjw&s=100, createdBy=44e32581133, createdName=圆圈, createdTime=Tue Jul 16 07:22:48 CST 2024, time=2024-07-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204586, encodeId=948b2204586bd, content=under review两个半月了，有必要催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec646521427, createdName=ms6000001850112323, createdTime=Tue May 14 09:51:07 CST 2024, time=2024-05-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208315, encodeId=76a42208315dd, content=5.2号提交。5.11送审。6.1号审回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Tue Jun 04 20:40:58 CST 2024, time=2024-06-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2211742, encodeId=72562211e42a5, content=有没有大佬知道，返修可以调整部分作者排名顺序吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Wed Jun 26 15:30:42 CST 2024, time=2024-06-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2209010, encodeId=efa52209010b7, content=偏重的研究方向：医学;肿瘤 经验分享：刚submit，mark一下，接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Sat Jun 08 23:56:01 CST 2024, time=2024-06-08, status=1, ipAttribution=重庆)]

2024-06-26 ms3000001282718256 来自安徽省

有没有大佬知道，返修可以调整部分作者排名顺序吗?

33 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205400, encodeId=5af32205400f4, content=想请问一下，AS拒稿重投后，第二次分配的审稿人跟第一次的审稿人一样吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0fcd2189796, createdName=1208f9b9m90暂无昵称, createdTime=Sat May 18 19:06:39 CST 2024, time=2024-05-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209274, encodeId=1d4122092e4b4, content=偏重的研究方向：医学;基础医学 经验分享：大佬们，想请教一下，论文送审后拒概率高吗🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db8a9106668, createdName=ms4000000919063399, createdTime=Mon Jun 10 22:52:28 CST 2024, time=2024-06-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2191477, encodeId=7f9a21914e7ed, content=偏重的研究方向：临床医学 经验分享：这个和cell reports比怎么样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec79194879, createdName=ms1000001659923753, createdTime=Wed Mar 06 14:57:14 CST 2024, time=2024-03-06, status=1, ipAttribution=密苏里), GetPortalCommentsPageByObjectIdResponse(id=2199501, encodeId=993e2199501d6, content=偏重的研究方向：医学 经验分享：投了三个月，under review了快三个月，不知道还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff0e9138354, createdName=ms1000000197918585, createdTime=Sat Apr 20 22:11:40 CST 2024, time=2024-04-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2215173, encodeId=aa9122151e352, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学 经验分享：这个期刊太慢了，一审3个多月，又搞了二轮三轮，然后本来都预接收了，结果因为刚开始投稿的时候系统里多写了一个作者的名字，最后三审修回的时候才发现就给系统里删了，但是文章里作者没变，编辑让我解释，我回信解释后编辑又说送reviewer外审了。。。。有没有人和我一样的情况的？为啥三个审稿人都同意发表了只是系统里更改了填错的作者就要重新送审啊？难道又要拖好几个月吗。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=FNCj07F0t899iaIQqGfFvjw&s=100, createdBy=44e32581133, createdName=圆圈, createdTime=Tue Jul 16 07:22:48 CST 2024, time=2024-07-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2194673, encodeId=d9ed21946e3b2, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：基础医学 经验分享：感觉有必要分享下经验。去年投稿AS,一审超过2个月，给了修改意见，3个审稿人，补实验修回后，二审很快，差不多两周，2个审稿人同意发表，1个审稿人说了一大堆不满意的，结果编辑给了拒稿重投的决定。这种情况以往经验来看，结果不会太好，但发现那个审稿人不熟悉这个领域，意见在逻辑上有漏洞。因此又补了点实验，决定重投。经过2个月Under Review, 突然收到来信，直接接收，一个字不用改了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf192349467, createdName=122aa381m91(暂无昵称), createdTime=Fri Mar 22 14:13:39 CST 2024, time=2024-03-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204586, encodeId=948b2204586bd, content=under review两个半月了，有必要催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec646521427, createdName=ms6000001850112323, createdTime=Tue May 14 09:51:07 CST 2024, time=2024-05-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208315, encodeId=76a42208315dd, content=5.2号提交。5.11送审。6.1号审回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Tue Jun 04 20:40:58 CST 2024, time=2024-06-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2211742, encodeId=72562211e42a5, content=有没有大佬知道，返修可以调整部分作者排名顺序吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cfda5588381, createdName=ms3000001282718256, createdTime=Wed Jun 26 15:30:42 CST 2024, time=2024-06-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2209010, encodeId=efa52209010b7, content=偏重的研究方向：医学;肿瘤 经验分享：刚submit，mark一下，接好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Sat Jun 08 23:56:01 CST 2024, time=2024-06-08, status=1, ipAttribution=重庆)]

2024-06-08 沧海医僧笑来自重庆

偏重的研究方向：医学;肿瘤
经验分享：刚submit，mark一下，接好运

37 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务